Initial experience with technetium-99m HM-PAO brain SPECT

J Nucl Med. 1987 Nov;28(11):1657-66.

Abstract

Technetium-99m hexamethylpropyleneamineoxime ([99mTc]HM-PAO) brain single photon emission computed tomography (SPECT) was performed with a dual head rotating scintillation camera. Normal tracer distribution and side/side differences of counting rates were obtained in 11 healthy volunteers. Almost stable gray/white matter ratios were found (1.97-2.1) in one normal subject during 2 hr after tracer administration. Eighty-three investigated patients had the following diagnoses (in parentheses is percent of positive findings in each group): cerebral vascular disease 18 (94.4%), epilepsy 23 (82.6%), extrapyramidal disorders 8 (100%), dementia 12 (100%), headache 11 (63.6%), psychiatric disorders 11 (27.3%). In addition, SPECT was performed in 28 male volunteers during motor or visual imagery tasks and a significant increase (p = 0.035) of relative tracer deposition was observed in the left inferior occipital region during visual imagery when compared with motor imagery. The results indicate that [99mTc]HM-PAO SPECT is valuable for demonstrating pathologic and physiologic changes of the brain.

MeSH terms

  • Adult
  • Aged
  • Basal Ganglia Diseases / diagnostic imaging
  • Brain / diagnostic imaging*
  • Cerebrovascular Circulation
  • Cerebrovascular Disorders / diagnostic imaging
  • Dementia / physiopathology
  • Epilepsy / diagnostic imaging
  • Female
  • Headache / diagnostic imaging
  • Humans
  • Imagination / physiology
  • Male
  • Mental Disorders / physiopathology
  • Middle Aged
  • Organometallic Compounds*
  • Oximes*
  • Technetium Tc 99m Exametazime
  • Technetium*
  • Tomography, Emission-Computed*

Substances

  • Organometallic Compounds
  • Oximes
  • Technetium Tc 99m Exametazime
  • Technetium